Study of 3M™ V.A.C.® Peel and Place Dressing for Wound Care

This study is looking at how safe and effective the 3M™ V.A.C.® Peel and Place Dressing is when used with 3M™ V.A.C.® Therapy for wound healing. We want to see if this dressing helps wounds heal well after it's already available on the market. You might be able to join if you are at least 22 years old and have a wound that your doctor thinks would benefit from this type of treatment. The main goal is to track any side effects (adverse events) that happen within 14 days of using the dressing. The study plans to enroll 90 participants.

Study design
This is a single-arm study, meaning all participants receive the same treatment, and it plans to enroll 90 people.
What's involved
Your participation could last up to 20 days, including a screening period, initial treatment, dressing changes as needed, and a final visit between 7 and 14 days after the first dressing application.
Compensation
Not stated in the trial record.
Follow-up
Your safety will be monitored for up to 14 days after the initial dressing application.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06625385

A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing

Recruiting
NAAges 22+InterventionalTreatment
Solventum US LLC
~90 participants
Updated 2026-02-13 on ClinicalTrials.gov
What's tested:3M™ V.A.C.® Peel and Place Dressing

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of (ADEs)
Measured over 14 days
Wound
3 sites across 3 states
Indiana1
Missouri1
Pennsylvania1
  • Stephanie Karwedsky · STUDY_DIRECTOR · Solventum

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

an open wound: traumatic wound, dehisced surgical wound within 30 days of surgery, burn, venous ulcer, diabetic ulcer, or pressure ulcer Note: Prior to initial placement, the wound may be debrided, as clinically indicated
a closed or covered wound secured with sutures or staples: closed surgical incision, skin flap closure, or skin graft (recipient site) 4. Subject is willing and able to attend all study visits.

Exclusion

an ankle brachial index \< 0.8;
no palpable pulse; or
no discernable audio Doppler signal.
any previous negative pressure wound therapy device.
growth factors.
bioengineered tissue products, eg, skin or dermal substitutes. 9. Wound was closed with tissue adhesive. 10. Wound has, in the opinion of the Investigator, any characteristic that would make it unsuitable for the study.
  • Incidence of (ADEs)14 days

    The incidence of adverse device effects (ADEs)